ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P13
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -3.73% |
| 2024 | 33.93% |
| 2023 | 38.09% |
| 2022 | 8.48% |
| 2021 | -6.43% |
| 2020 | 166.00% |
| 2019 | 20.07% |
| 2018 | -0.52% |
| 2017 | 0.00% |